Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3251097
Max Phase: Preclinical
Molecular Formula: C18H24N2O6
Molecular Weight: 274.36
Molecule Type: Small molecule
Associated Items:
ID: ALA3251097
Max Phase: Preclinical
Molecular Formula: C18H24N2O6
Molecular Weight: 274.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC(=O)Oc1ccc2[nH]cc(CCN(C)C)c2c1.O=C(O)C(=O)O
Standard InChI: InChI=1S/C16H22N2O2.C2H2O4/c1-4-5-16(19)20-13-6-7-15-14(10-13)12(11-17-15)8-9-18(2)3;3-1(4)2(5)6/h6-7,10-11,17H,4-5,8-9H2,1-3H3;(H,3,4)(H,5,6)
Standard InChI Key: DHZRUEDWIKEINV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 274.36 | Molecular Weight (Monoisotopic): 274.1681 | AlogP: 2.98 | #Rotatable Bonds: 6 |
Polar Surface Area: 45.33 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.56 | CX LogP: 3.05 | CX LogD: 0.91 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.65 | Np Likeness Score: -0.24 |
1. Glennon RA, Gessner PK, Godse DD, Kline BJ.. (1979) Bufotenine esters., 22 (11): [PMID:533890] [10.1021/jm00197a025] |
Source(1):